Serial quantitation of AML1-MTG8 transcripts in 9 patients with t(8;21) acute myeloid leukemia (AML).

Results with bone marrow (BM) (A) and peripheral blood (PB) (B) samples are shown. Patients 3, 5, 7, 8, and 18 had a relapse (R), whereas patients 1, 2, 4, and 11 are in continuous remission. Levels of 1.00E-01 are reverse transcriptase-polymerase chain reaction (RT-PCR) negative.